Brokerages Set National Health Investors, Inc. (NYSE:NHI) PT at $86.83

National Health Investors, Inc. (NYSE:NHI) has been given an average rating of “Moderate Buy” by the seven brokerages that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $86.8333.

NHI has been the subject of a number of analyst reports. Truist Financial boosted their price target on National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a research note on Thursday, March 12th. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research note on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 price target on National Health Investors in a research note on Monday, January 5th. National Bank Financial set a $85.00 price target on National Health Investors in a research note on Tuesday, January 20th. Finally, Wells Fargo & Company boosted their price target on National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a research note on Friday, March 27th.

National Health Investors Stock Down 1.4%

NHI opened at $85.31 on Friday. National Health Investors has a fifty-two week low of $68.80 and a fifty-two week high of $91.38. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The company has a market capitalization of $4.13 billion, a P/E ratio of 28.25, a P/E/G ratio of 4.69 and a beta of 0.63. The stock has a fifty day moving average of $85.37 and a 200-day moving average of $80.19.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). The company had revenue of $105.82 million during the quarter, compared to analyst estimates of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm earned $1.24 EPS. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, equities analysts expect that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s payout ratio is 121.85%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Woodmont Investment Counsel LLC raised its stake in National Health Investors by 23.9% during the third quarter. Woodmont Investment Counsel LLC now owns 96,287 shares of the real estate investment trust’s stock worth $7,655,000 after acquiring an additional 18,582 shares in the last quarter. Strs Ohio raised its stake in National Health Investors by 293.6% during the third quarter. Strs Ohio now owns 167,300 shares of the real estate investment trust’s stock worth $13,300,000 after acquiring an additional 124,800 shares in the last quarter. Tudor Investment Corp ET AL raised its stake in National Health Investors by 189.8% during the third quarter. Tudor Investment Corp ET AL now owns 116,570 shares of the real estate investment trust’s stock worth $9,267,000 after acquiring an additional 76,339 shares in the last quarter. Bowen Hanes & Co. Inc. raised its stake in National Health Investors by 30.0% during the third quarter. Bowen Hanes & Co. Inc. now owns 260,000 shares of the real estate investment trust’s stock worth $20,670,000 after acquiring an additional 60,000 shares in the last quarter. Finally, Centersquare Investment Management LLC raised its stake in National Health Investors by 21.8% during the third quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock worth $78,443,000 after acquiring an additional 176,410 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.